Long-term safety and efficacy of omeprazole in gastro-oesophageal reflux disease

被引:10
作者
Armstrong, D [1 ]
机构
[1] McMaster Univ, Med Ctr, Div Gastroenterol, Hamilton, ON L8N 3Z5, Canada
关键词
D O I
10.1016/S0140-6736(00)02598-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:610 / 612
页数:3
相关论文
共 15 条
  • [1] Proton pump inhibitor-associated gastric polyps - A retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics
    Choudhry, U
    Boyce, HW
    Coppola, D
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1998, 110 (05) : 615 - 621
  • [2] Safety profile of lansoprazole - The US clinical trial experience
    Freston, JW
    Rose, PA
    Heller, CA
    Haber, M
    Jennings, D
    [J]. DRUG SAFETY, 1999, 20 (02) : 195 - 205
  • [4] SAFETY EXPERIENCE FROM LONG-TERM TREATMENT WITH OMEPRAZOLE
    JOELSON, S
    JOELSON, IB
    LUNDBORG, P
    WALAN, A
    WALLANDER, MA
    [J]. DIGESTION, 1992, 51 : 93 - 101
  • [5] Long-term omeprazole treatment in resistant gastroesophageal reflux disease:: Efficacy, safety, and influence on gastric mucosa
    Klinkenberg-Knol, EC
    Nelis, F
    Dent, J
    Snel, P
    Mitchell, B
    Prichard, P
    Lloyd, D
    Havu, N
    Frame, MH
    Romàn, J
    Walan, A
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : 661 - 669
  • [6] The efficacy and safety of long-term omeprazole treatment for gastroesophageal reflux disease
    Kuipers, EJ
    Meuwissen, SGM
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : 795 - 798
  • [7] KUIPERS EJ, 1996, N ENGL J MED, V334
  • [8] Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
    Lagergren, J
    Bergström, R
    Lindgren, A
    Nyrén, O
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (11) : 825 - 831
  • [9] Laine L, 2000, ALIMENT PHARM THER, V14, P651
  • [10] Lind T, 1999, ALIMENT PHARM THERAP, V13, P907